Zhao Wang1,2, Fabio Carniato3, Yijun Xie1,4
1Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, 92093, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers developed gadolinium-polydopamine nanoparticles (GdPD-NPs) for MRI. These nanoparticles exhibit high relaxivity, making them promising T1-weighted contrast agents.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: